ASPIRIN

💡

Quick Summary

Aspirin is a salicylate that irreversibly acetylates and inhibits the cyclooxygenase (COX-1 and COX-2) enzymes, halting the synthesis of prostaglandins and thromboxanes. While it remains a ubiquitous over-the-counter analgesic and antipyretic, its dominant clinical significance lies in cardiovascular medicine: by permanently disabling platelet COX-1, it suppresses thromboxane A2 production for the entire 7-to-10-day lifespan of the platelet, providing rapid and profound antiplatelet aggregation. This irreversible mechanism makes chewable, non-enteric-coated aspirin the single most critical immediate intervention in acute myocardial infarction. However, this same systemic COX-1 inhibition strips the gastrointestinal tract of its protective prostaglandin mucosal layer, making dose-dependent gastrointestinal bleeding and ulceration the primary limiting factor across all indications.

🔬

Drug Identity

GENERIC NAMEAspirin
MEDOBO IDMDBD0002
ATC CODEB01AC06
DRUG CLASSNSAID
PHARMACOLOGICAL CLASSSalicylate
THERAPEUTIC CLASSAntiplatelet, Analgesic, Antipyretic
THERAPEUTIC CATEGORYCardiovascular
CHEMICAL NAME2-acetoxybenzoic acid
DRUG SOURCESynthetic
FDA APPROVAL1899
MODALITYSmall Molecule
DRUG TYPEstandard
MARKET STATUS● Approved
CORE USE TAGS
AntiplateletNSAIDAnalgesicAntipyreticCardiovascular Prevention
BRAND NAMES (GLOBAL)
BayerEcotrinBufferinAnacinDisprinAsproCardiopirinNu-SealsAstrixCartiaSolvprinAscriptinMicristinPlatetSolprin
SYNONYMS
Acetylsalicylic acidASA2-acetoxybenzoic acidO-acetylsalicylic acidAcylpyrin
📌

Indications & Uses

🎯 APPROVED INDICATIONS
  • Acute myocardial infarction — administered immediately to reduce the risk of death and nonfatal recurrent infarction
  • Secondary prevention of cardiovascular mortality and recurrent myocardial infarction in patients with established coronary artery disease
  • Secondary prevention of ischemic stroke and transient ischemic attacks (TIA) to reduce the risk of recurrent cerebrovascular events
  • Management of unstable angina and chronic stable angina pectoris
  • Relief of mild to moderate pain, including headache, toothache, dysmenorrhea, and musculoskeletal pain
  • Reduction of fever and relief of associated aches and pains
  • Treatment of inflammatory conditions such as rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis at high analgesic doses
  • Rheumatic fever — as a primary anti-inflammatory and antipyretic agent
🔬 OFF-LABEL USES
  • Pre-eclampsia prevention in high-risk pregnancies — low-dose aspirin (75–150 mg daily) initiated before 16 weeks gestation is strongly recommended by ACOG and USPSTF guidelines
  • Kawasaki disease — high-dose anti-inflammatory therapy followed by low-dose antiplatelet therapy in the acute and convalescent phases per American Heart Association (AHA) guidelines
  • Primary prevention of cardiovascular disease in select high-risk patients — though recent major trials (ASPREE, ARRIVE, ASCEND) have largely restricted this use due to bleeding risks outweighing benefits in most primary prevention cohorts
  • Colorectal cancer prevention in patients with Lynch syndrome or high cardiovascular risk who also meet criteria for long-term use — historically supported by USPSTF, though recent guidance has become more nuanced regarding age and bleeding risk
MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current prescribing information, institutional protocols, and official clinical guidelines. Medobo is not responsible for clinical decisions made based on this content.